1-6 of 6
Stephen A Beers, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Activates NOTCH1 Signaling in CLL Cells and Induces Changes in the Cytokine Repertoire Favoring a Tumor-Protective Microenvironment

Jennifer Edelmann, MD PhD, Karlheinz Holzmann, Dr. rer. nat., Doriana DiBella, Emma Vilventhraraja, Stephen A Beers, PhD, Mark Cragg, PhD, Andrejs Braun, PhD, John G. Gribben, MDDSc FMedSci
Journal: Blood
Blood (2017) 130 (Supplement 1): 2996.
https://doi.org/10.1182/blood.V130.Suppl_1.2996.2996
Published: 2017
Journal Articles

In Chronic Lymphocytic Leukemia ΔCT7544-7545 Mutant NOTCH1 Maintains Transcription Factor Activity with Longer Lasting Effects Due to Slower Degradation

Jennifer Edelmann, MD, Tetyana Klymenko, PhD, Chen Lu, PhD, Emma Vilventhraraja, Sven Estenfelder, Eugen Tausch, Stephen A Beers, PhD, Stephan Stilgenbauer, Mark S Cragg, PhD, Andrejs Ivanov, PhD, John Gribben
Journal: Blood
Blood (2016) 128 (22): 971.
https://doi.org/10.1182/blood.V128.22.971.971
Published: 2016
Journal Articles

Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment

Anna H Turaj, MSc, Vikki L Field, Claude H.T. Chan, PhD, Christine A. Penfold, BSc, Jinny H. Kim, PhD, Sonya James, PhD, Kerry L Cox, Tibor Keler, PhD, Peter M Johnson, MA, MD, Aymen Al-Shamkhani, PhD, Stephen A Beers, PhD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Sean H Lim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3024.
https://doi.org/10.1182/blood.V128.22.3024.3024
Published: 2016
Journal Articles

Defining Immune Response Signatures in DLBCL As Potential Predictive Biomarkers for Outcome to Immunotherapy

Matthew A Care, PhD, Stephen M Thirdborough, PhD, Andrew J Davies, MRCP PhD, Peter W.M. Johnson, FRCP, Andrew Jack, PhD MB, Sharon Barrans, PhD, David R Westhead, PhD, Mark S Cragg, PhD, Reuben M Tooze, PhD FRCP, Stephen A Beers, PhD
Journal: Blood
Blood (2015) 126 (23): 2663.
https://doi.org/10.1182/blood.V126.23.2663.2663
Published: 2015
Journal Articles

New-Generation Anti-CD20 Monoclonal Antibody (GA101) Evokes Homotypic Adhesion and Actin-Dependent, Lysosome-Mediated Cell Death in B-Cell Lymphoma.

Waleed Alduaij, MRes, Sandeep Potluri, BA, Andrei Ivanov, PhD, Jamie Honeychurch, PhD, Stephen A Beers, PhD, Claude Chan, PhD, Kazayuki Shimada, MD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Tim Illidge, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 725.
https://doi.org/10.1182/blood.V114.22.725.725
Published: 2009
Journal Articles

Novel Mechanisms of Non-Apoptotic Cell Death Evoked by Type II Anti-CD20 (Tositumomab) and HLA-DR Monoclonal Antibodies

Tim Illidge, MD, PhD, Andrei Ivanov, PhD, Stephen A Beers, PhD, Claire Walshe, PhD, Claude Chan, PhD, Waleed Alduaij, Martin J. Glennie, PhD, Mark S Cragg
Journal: Blood
Blood (2008) 112 (11): 883.
https://doi.org/10.1182/blood.V112.11.883.883
Published: 2008